DoW Toxic Exposures Translational Research Award

The DoW Toxic Exposures Translational Research Award aims to support translational research that will accelerate the movement of promising ideas in military-related toxic exposure research into clinical applications. The award includes a Partnering Principal Investigator Option to encourage meaningful and productive collaborations between investigators. Applications should provide evidence for the reciprocal transfer of information between basic and clinical science and demonstrate the potential for significant impact on military-related toxic exposure research and/or patient care. Key areas of focus include predicting and preventing adverse effects of exposures to toxic substances, understanding the full range of effects from military-related environmental and toxic exposures, and developing diagnostic screens and treatments for toxic exposures. • The award is open to extramural and intramural U.S. Department of War organizations, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities. • The maximum period of performance is 3 years, with a total cost cap of $1.5M per award. • The CDMRP expects to allot roughly $6.0M to fund approximately four Translational Research Award applications. • Applications should include preliminary data to support feasibility of the study and demonstrate the potential for significant impact on military-related toxic exposure research and/or patient care.